Evidence-Based Treatment for Obsessive-Compulsive Disorder (OCD) and Generalized Anxiety Disorder (GAD)

First-Line Treatment for OCD

The American College of Psychiatrists recommends Cognitive-Behavioral Therapy with Exposure and Response Prevention (CBT with ERP) as the psychological treatment of choice for OCD, demonstrating superior efficacy with a number needed to treat of 3 compared to 5 for SSRIs 1
CBT with ERP involves gradual exposure to fear-provoking stimuli combined with instructions to abstain from compulsive behaviors, and patient adherence to between-session homework exercises is the strongest predictor of good short-term and long-term outcomes 2
The International College of Obsessive-Compulsive Spectrum Disorders suggests that CBT can be delivered individually, in groups, or via internet-based protocols with equivalent effectiveness 2
The National Institute of Mental Health recommends SSRIs as the first-line pharmacological treatment for OCD based on established efficacy, tolerability, safety, and absence of abuse potential 2, 1

Higher doses of SSRIs are required for OCD compared to depression or other anxiety disorders, with higher doses associated with greater efficacy but also higher dropout rates due to adverse effects 2
The World Health Organization notes that all SSRIs demonstrate similar efficacy for OCD; selection should be based on side effect profile, drug interactions, comorbid medical conditions, and cost 3
The European College of Neuropsychopharmacology recommends allowing 8-12 weeks at maximum tolerated dose before declaring treatment failure, though significant improvement may be observed within the first 2 weeks with greatest incremental gains occurring early in treatment 3, 2
The American Psychiatric Association suggests maintaining treatment for a minimum of 12-24 months after achieving remission due to high relapse risk 3, 1

The International College of Obsessive-Compulsive Spectrum Disorders recommends that when first-line treatment fails after adequate trials, increase SSRI dose beyond maximum recommended dose for depression, switch to a different SSRI, or trial of clomipramine 3
CBT augmentation of SSRIs shows larger effect sizes than antipsychotic augmentation, and antipsychotic augmentation has evidence of efficacy, though only one-third of SSRI-resistant patients show clinically meaningful response with small effect sizes 3

The American College of Psychiatrists prioritizes mood stabilization first with mood stabilizers plus CBT, avoiding SSRIs as monotherapy due to risk of mood destabilization in patients with comorbid bipolar 2 disorder and OCD 4

The National Institute of Mental Health notes that OCD requires higher SSRI doses and longer trial duration (8-12 weeks) compared to GAD 3, 2
The European College of Neuropsychopharmacology recommends CBT with ERP specifically for OCD, while general CBT approaches are used for GAD 2
The World Health Organization suggests that approximately 50% of OCD patients fail to respond to first-line treatment, requiring more aggressive augmentation strategies compared to GAD 3